|CEO Dr. Robert Clarke of Pulmatrix Inc. (NASDAQ: PULM)|
CEO Dr. Robert Clarke of Pulmatrix Inc. (NASDAQ: PULM), joins Uptick Newswire to discuss the development of inhaled therapies to address serious pulmonary disease.
The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.
Source: Uptick Newswire